广州新济药业科技

Guangzhou Xinji Pharmaceutical Technology is a high-tech enterprise specializing in the research and development of high-end drug delivery systems and complex formulations. Founded by Dr. Wu Chuanbin, the company focuses on 505(b)(2) drug development and provides CRO/CDMO services for complex injectables, transdermal systems, and oral solids. Their technology portfolio includes microspheres, liposomes, nanocrystals, and dissolving microneedles. Xinji Pharma aims to improve patient compliance and therapeutic efficacy through innovative formulation strategies, particularly in the fields of central nervous system disorders, ophthalmology, and oncology. The company operates a comprehensive R&D center and GMP-compliant pilot production lines to support the transition from laboratory discovery to clinical manufacturing.